A gigantic bulge in the north rim of the Yellowstone caldera is the latest sign of volcanic activity in the national park.
The bispecific antibody—which targets the IL-23p19 and TL1A pathways—was licensed from China’s Qyuns Therapeutics. Since being founded last year, Caldera has already taken the therapy, dubbed CLD-423, ...
Scientists are monitoring a city of Chicago-sized swath of rising ground at the northern volcanic rim of the Yellowstone ...
Yellowstone is a dynamic geologic system—the one constant is change. This is demonstrated daily by hydrothermal activity ...
The biotech is advancing a bispecific medicine aimed at two popular targets and being billed as a potential therapeutic ...
Discover how Caldera International is transforming pet care with innovative heated and therapeutic solutions for improved comfort and health. CANBY, OR, UNITED STATES, January 6, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results